161 related articles for article (PubMed ID: 15180466)
1. Immunopathogenesis of psoriasis.
Ozawa M; Aiba S
Curr Drug Targets Inflamm Allergy; 2004 Jun; 3(2):137-44. PubMed ID: 15180466
[TBL] [Abstract][Full Text] [Related]
2. The cell-components and cytokines in the subcorneal microabscess of psoriasis.
Kaneko F; Itoh N; Yoshida H; Suzuki M; Ono I
Fukushima J Med Sci; 1991 Dec; 37(2):103-12. PubMed ID: 1823882
[TBL] [Abstract][Full Text] [Related]
3. T cells involved in psoriasis vulgaris belong to the Th1 subset.
Schlaak JF; Buslau M; Jochum W; Hermann E; Girndt M; Gallati H; Meyer zum Büschenfelde KH; Fleischer B
J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
5. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
Albanesi C; De Pità O; Girolomoni G
Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
[TBL] [Abstract][Full Text] [Related]
6. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells.
Kaneko F; Suzuki M; Takiguchi Y; Itoh N; Minagawa T
J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953
[TBL] [Abstract][Full Text] [Related]
7. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M
Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
[TBL] [Abstract][Full Text] [Related]
8. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
[TBL] [Abstract][Full Text] [Related]
9. Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact.
Martin G; Guérard S; Fortin MM; Rusu D; Soucy J; Poubelle PE; Pouliot R
Lab Invest; 2012 Jul; 92(7):1058-70. PubMed ID: 22525430
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
11. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
Shen Z; Wang G; Fan JY; Li W; Liu YF
J Dermatol Sci; 2005 Apr; 38(1):25-39. PubMed ID: 15795121
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
[TBL] [Abstract][Full Text] [Related]
13. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy.
Rácz E; Prens EP
Expert Rev Mol Med; 2009 Dec; 11():e38. PubMed ID: 20003607
[TBL] [Abstract][Full Text] [Related]
15. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.
Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J
J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243
[TBL] [Abstract][Full Text] [Related]
16. The immunopathogenesis of psoriasis.
Kim J; Krueger JG
Dermatol Clin; 2015 Jan; 33(1):13-23. PubMed ID: 25412780
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
18. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
[TBL] [Abstract][Full Text] [Related]
20. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
